Search Results

Displaying Results 1-1 of 1 "'ARQT'"

Mar 27, 2026, 08:36 ET Stratum Biosciences Secures $2M Seed Round to Accelerate AI-Powered Skin Biology Discovery and Expanded R&D Partnerships

been able to make in such a short amount of time has been remarkable," said Chief Scientific Officer Dr. David Osborne, former co-founder of Arcutis (ARQT)."It's exciting to take my career experience and use the platform and methodology created by Stratum to rewrite our understanding of dermatology

More news about: Stratum Biosciences


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.